★ Sign in to follow
MZ

Maurice Zauderer

Executive
Chief Executive Officer
US·SEC (Form 4)
Vaccinex, Inc.
Total declarations
21
Company
1
▲ Purchases (6 ops.)
€3.4M
▼ Sales (0 ops.)
—

Latest filing published 18 Nov 2024 for Vaccinex, INC., €142k.

Filing timeline

BuySale
Maurice Zauderer

Insider track record

Disclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.6%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Maurice Zauderer: trading record in brief

Maurice Zauderer (chief executive) discloses dealings in Vaccinex, Inc. to SEC (Form 4). Over a trading history stretching from 13 August 2018 to 14 November 2024, the count stands at 21 filings.

Every open-market trade on record is a purchase: 6 purchases worth €3.4M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 share grants and 4 option exercises.

A typical purchase (the median) is worth €464k. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 18 November 2024 with a share grant (€142k) in Vaccinex, Inc. The most recent open-market purchase was published on 5 October 2023, 1,130 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Maurice Zauderer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ◆
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    149,997 USD33SEC
    46,153 shares@ US$3.252.3% of flowCommon StockSEC:0001062993-24-019265:0
  • ◇
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    217,606 USD35SEC
    38,610 shares@ US$5.6363.1% of flowCommon StockSEC:0001062993-24-016842:0
  • ◆
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    300,000 USD35SEC
    38,610 shares@ US$7.774.4% of flowCommon StockSEC:0001062993-24-007661:0
  • ◆
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    300,000 USD35SEC
    413,793 shares@ US$0.7254.4% of flowCommon StockSEC:0001062993-24-002770:0
  • ▲
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    500,000 USD46SEC
    500,000 shares@ US$1.007.6% of flowCommon StockSEC:0001062993-23-019063:0
    Canonical exit: 1 Jan 2024 (T+90)
  • ◆
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    320,000 USD34SEC
    2,051,282 shares@ US$0.1565.6% of flowCommon StockSEC:0001062993-23-018438:0
  • ◆
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    300,000 USD33SEC
    731,707 shares@ US$0.414.4% of flowCommon StockSEC:0001062993-23-008320:0
  • ●
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    0SEC
    3,988 shares0Common StockSEC:0001062993-22-023491:0
  • ◆
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    800,000 USD38SEC
    1,511,430 shares@ US$0.529312.4% of flowCommon StockSEC:0001062993-22-022815:0
  • ▲
    Maurice Zauderer
    President and CEOExecutivesVaccinex, Inc.
    2M USD45SEC
    1,801,801 shares@ US$1.1139.5% of flowCommon StockSEC:0001062993-22-001866:0
    Canonical exit: 27 Apr 2022 (T+90)

10 of 10 declarations

Related entities

No related entities found.